Poynard, T.; Deckmyn, O.; Pais, R.; Aron-Wisnewsky, J.; Peta, V.; Bedossa, P.; Charlotte, F.; Ponnaiah, M.; Siksik, J.-M.; Genser, L.;
et al. Three Neglected STARD Criteria Reduce the Uncertainty of the Liver Fibrosis Biomarker FibroTest-T2D in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Diagnostics 2025, 15, 1253.
https://doi.org/10.3390/diagnostics15101253
AMA Style
Poynard T, Deckmyn O, Pais R, Aron-Wisnewsky J, Peta V, Bedossa P, Charlotte F, Ponnaiah M, Siksik J-M, Genser L,
et al. Three Neglected STARD Criteria Reduce the Uncertainty of the Liver Fibrosis Biomarker FibroTest-T2D in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Diagnostics. 2025; 15(10):1253.
https://doi.org/10.3390/diagnostics15101253
Chicago/Turabian Style
Poynard, Thierry, Olivier Deckmyn, Raluca Pais, Judith Aron-Wisnewsky, Valentina Peta, Pierre Bedossa, Frederic Charlotte, Maharajah Ponnaiah, Jean-Michel Siksik, Laurent Genser,
and et al. 2025. "Three Neglected STARD Criteria Reduce the Uncertainty of the Liver Fibrosis Biomarker FibroTest-T2D in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)" Diagnostics 15, no. 10: 1253.
https://doi.org/10.3390/diagnostics15101253
APA Style
Poynard, T., Deckmyn, O., Pais, R., Aron-Wisnewsky, J., Peta, V., Bedossa, P., Charlotte, F., Ponnaiah, M., Siksik, J.-M., Genser, L., Clement, K., Leanour, G., & Valla, D.
(2025). Three Neglected STARD Criteria Reduce the Uncertainty of the Liver Fibrosis Biomarker FibroTest-T2D in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Diagnostics, 15(10), 1253.
https://doi.org/10.3390/diagnostics15101253